Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-15T07:09:04.000Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply to Drekonja

Published online by Cambridge University Press:  02 January 2015

Stuart H. Cohen ,
Dale N. Gerding  and
Stuart Johnson
Stuart H. Cohen
Affiliation:
Department of Internal Medicine, Division of Infectious and Immunologic Diseases, University of California Davis Medical Center, Sacramento
Dale N. Gerding
Affiliation:
Research Service, Edward Hines Jr Veterans Administration Hospital, and the Infectious Disease Division, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
Stuart Johnson
Affiliation:
Research Service, Edward Hines Jr Veterans Administration Hospital, and the Infectious Disease Division, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue 11 , November 2010 , pp. 1205 - 1206
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

References

1.Drekonja, DM. Rifampin plus metronidazole for Clostridium difficile infection. Infect Control Hosp Epidemiol 2010;31(11):1205 (in this issue).CrossRefGoogle ScholarPubMed
2.Lagrotteria, D, Holmes, S, Smieja, M, Smaili, F, Lee, C. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. Clin Infect Dis 2006;43:547–552.CrossRefGoogle ScholarPubMed
3.Cohen, SH, Gerding, DN, Johnson, S, et al.Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(11):431–455.Google Scholar